Longevity biotech stocks see surge as $27 trillion healthcare shift favors cell restoration by 2030.
Avant Technologies Inc., based in Vancouver, BC, issued a news release on Jan. 29, 2026, stating that global capital is shifting towards "Longevity Infrastructure," which is anticipated to reach a value of $27 trillion by 2030. This significant transition is impacting various sectors and industries.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments